Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone
- 1 August 2001
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 78 (2) , 137-143
- https://doi.org/10.1016/s0960-0760(01)00091-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The pharmacological profile of a novel norpregnane progestin (trimegestone)Gynecological Endocrinology, 1999
- Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPIPublished by American Medical Association (AMA) ,1996
- The antiovulatory activity of progesterone antagonists is not correlated to their antiprogestational potency in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA, 1996
- Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.Genes & Development, 1995
- Progesterone regulation of heparin-binding epidermal growth factor-like growth factor gene expression during sensitization and decidualization in the rat uterus: effects of the antiprogestin, ZK 98.299Endocrinology, 1994
- Progesterone Regulation of Estradiol-Induced Rat Uterine Secretory Protein, Complement C31Biology of Reproduction, 1990
- Hormonal Control of OvoimplantationPublished by Elsevier ,1974
- The Effects of Various Steroids on the Vaginal Histology in the RatFertility and Sterility, 1973
- The assay of progestinThe Journal of Physiology, 1934